Rein Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Rein Therapeutics, Inc. (RNTX) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$662.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-14
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$909.00K.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $247.00K.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $584.00K, a 126.36% increase year-over-year.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$34.00K, a 107.98% decline year-over-year.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$2.62M, a 255.06% decline from fiscal 2024.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.69M.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$382.00K.
- Rein Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$1.57M, a 256.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$662.00K 10-Q · filed 2026-08-14 | -$78.00K derived: sum of 3 quarters · filed 2026-08-14 | -$112.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $247.00K 10-Q · filed 2026-05-15 | $831.00K derived: sum of 2 quarters · filed 2026-05-15 | $797.00K derived: sum of 3 quarters · filed 2026-05-15 | -$2.37M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $550.00K derived: sum of 2 quarters · filed 2026-03-26 | -$2.61M derived: sum of 3 quarters · filed 2026-08-14 | -$2.62M 10-K · filed 2026-03-26 |
| 2025-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.20M derived: sum of 2 quarters · filed 2026-08-14 | -$3.21M 10-Q · filed 2025-11-14 | -$2.95M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.17M 10-Q · filed 2026-08-14 | -$2.91M derived: sum of 3 quarters · filed 2026-08-14 | -$2.49M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$10.00K 10-Q · filed 2026-05-15 | $248.00K derived: sum of 2 quarters · filed 2026-05-15 | $674.00K derived: sum of 3 quarters · filed 2026-05-15 | $2.45M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $684.00K derived: sum of 2 quarters · filed 2026-03-26 | $2.46M derived: sum of 3 quarters · filed 2026-03-26 | $1.69M 10-K · filed 2026-03-26 |
| 2024-09-30 | $426.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.20M derived: sum of 2 quarters · filed 2025-11-14 | $1.43M 10-Q · filed 2025-11-14 | $1.54M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.01M 10-Q · filed 2025-08-14 | $1.12M derived: sum of 3 quarters · filed 2025-08-14 | $1.20M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$771.00K 10-Q · filed 2025-05-15 | -$662.00K derived: sum of 2 quarters · filed 2025-05-15 | -$583.00K derived: sum of 3 quarters · filed 2025-05-15 | -$1.95M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $188.00K derived: sum of 2 quarters · filed 2025-04-07 | -$1.18M derived: sum of 3 quarters · filed 2025-04-07 | -$382.00K 10-K · filed 2025-04-07 |
| 2023-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.29M derived: sum of 2 quarters · filed 2024-11-14 | -$491.00K 10-Q · filed 2024-11-14 | -$2.38M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$570.00K 10-Q · filed 2024-08-14 | -$2.46M derived: sum of 3 quarters · filed 2024-08-14 | -$2.25M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $795.00K 10-Q · filed 2024-05-15 | -$1.10M derived: sum of 2 quarters · filed 2024-05-15 | -$884.00K derived: sum of 3 quarters · filed 2024-05-15 | -$566.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | -$1.68M derived: sum of 2 quarters · filed 2024-04-15 | -$1.36M derived: sum of 3 quarters · filed 2024-04-15 | -$1.57M 10-K · filed 2024-04-15 |
| 2022-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | $532.00K derived: sum of 2 quarters · filed 2023-10-13 | $319.00K 10-Q · filed 2023-10-13 | $93.00K derived: sum of 4 quarters · filed 2023-10-13 |
| 2022-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $105.00K 10-Q · filed 2023-08-11 | -$121.00K derived: sum of 3 quarters · filed 2023-08-11 | $146.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$213.00K 10-Q · filed 2023-05-08 | -$439.00K derived: sum of 2 quarters · filed 2023-05-08 | -$172.00K derived: sum of 3 quarters · filed 2023-05-08 | $901.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $41.00K derived: sum of 2 quarters · filed 2023-03-20 | $1.11M derived: sum of 3 quarters · filed 2023-03-20 | $1.01M 10-K · filed 2023-03-20 |
| 2021-09-30 | $267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $1.34M derived: sum of 2 quarters · filed 2022-11-01 | $1.24M 10-Q · filed 2022-11-01 | -$128.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $968.00K 10-Q · filed 2022-08-15 | -$395.00K derived: sum of 3 quarters · filed 2022-08-15 | $82.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$105.00K 10-Q · filed 2022-05-05 | -$1.47M derived: sum of 2 quarters · filed 2022-05-05 | -$991.00K derived: sum of 3 quarters · filed 2022-05-05 | -$2.46M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$886.00K derived: sum of 2 quarters · filed 2022-03-28 | -$2.36M derived: sum of 3 quarters · filed 2022-03-28 | -$1.74M 10-K · filed 2022-03-28 |
| 2020-09-30 | $477.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$997.00K derived: sum of 2 quarters · filed 2021-11-12 | -$378.00K 10-Q · filed 2021-11-12 | -$94.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$855.00K 10-Q · filed 2021-08-11 | -$571.00K derived: sum of 3 quarters · filed 2021-08-11 | -$153.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $619.00K 10-Q · filed 2021-05-11 | $903.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.32M derived: sum of 3 quarters · filed 2021-05-11 | $1.38M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $702.00K derived: sum of 2 quarters · filed 2021-03-24 | $759.00K derived: sum of 3 quarters · filed 2021-03-24 | $385.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $475.00K derived: sum of 2 quarters · filed 2020-11-12 | $101.00K 10-Q · filed 2020-11-12 | -$471.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$317.00K 10-Q · filed 2020-08-05 | -$889.00K derived: sum of 3 quarters · filed 2020-08-05 | -$439.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$374.00K 10-Q · filed 2020-05-11 | -$946.00K derived: sum of 2 quarters · filed 2020-05-11 | -$496.00K derived: sum of 3 quarters · filed 2020-05-11 | $216.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$122.00K derived: sum of 2 quarters · filed 2020-03-30 | $590.00K derived: sum of 3 quarters · filed 2020-03-30 | $359.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $450.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.16M derived: sum of 2 quarters · filed 2019-11-07 | $931.00K 10-Q · filed 2019-11-07 | $1.06M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $712.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $481.00K 10-Q · filed 2019-08-06 | $612.00K derived: sum of 3 quarters · filed 2019-08-06 | $1.45M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$231.00K 10-Q · filed 2019-05-08 | -$100.00K derived: sum of 2 quarters · filed 2019-05-08 | $733.00K derived: sum of 3 quarters · filed 2019-05-08 | $1.43M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $964.00K derived: sum of 2 quarters · filed 2019-03-29 | $1.66M derived: sum of 3 quarters · filed 2019-03-29 | $1.22M 10-K · filed 2019-03-29 |
| 2017-09-30 | $833.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.53M derived: sum of 2 quarters · filed 2018-11-07 | $1.08M 10-Q · filed 2018-11-07 | $644.00K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $696.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $252.00K 10-Q · filed 2018-08-07 | -$189.00K derived: sum of 3 quarters · filed 2018-08-07 | $27.00K derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | -$444.00K 10-Q · filed 2018-05-09 | -$885.00K derived: sum of 2 quarters · filed 2018-05-09 | -$669.00K derived: sum of 3 quarters · filed 2018-05-09 | |
| 2016-12-31 | -$441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$225.00K derived: sum of 2 quarters · filed 2018-04-02 | $333.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $774.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $558.00K 10-Q · filed 2017-08-10 | |||
| 2015-12-31 | $584.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |